CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
Cognitive Behavioral Therapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02898597
NCT02898597N/ACompleted

Smoking Cessation Intervention for Women With HIV/AIDS

University of Massachusetts, Boston·interventional·Posted Sep 13, 2016·Updated Aug 5, 2019

In Brief

A clinical study evaluating Cognitive Behavioral Therapy for AIDS/HIV. Completed, enrolled 49 participants across 1 site.

Detailed Summary

As people with HIV/AIDS live longer, the burden of non-AIDS-related health problems such as cardiovascular diseases and cancers on these people have consistently increased. Smoking is one of the major contributing factors to these health problems and rates of cigarette smoking in this group are substantially higher than those of the general population: 40-70% vs. 17-10%. Especially, women living with HIV/AIDS seem to be more susceptible to the negative consequence of smoking than their male counterparts. They are also less likely to see tobacco dependence treatment for dual stigma associated with both conditions: HIV infection and nicotine addiction. This is a pilot study to develop smoking cessation intervention for these women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAIDS/HIV
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 13, 2016
Enrollment StartJun 1, 2016
Primary CompletionDec 1, 2017
Study CompletionAug 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.8 years ago

Interventions

Cognitive Behavioral Therapybehavioral

Received 8 weekly individualized counseling sessions of cognitive behavioral therapy